{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:45:17Z","timestamp":1791488717833,"version":"4.3.4"},"reference-count":46,"publisher":"Medical Association of Nippon Medical School","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2020,6,30]]},"DOI":"10.1272\/jnms.jnms.2020_87-303","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T22:04:09Z","timestamp":1577397849000},"page":"129-137","source":"Crossref","is-referenced-by-count":12,"title":["Intravenous Immunoglobulin Attenuates Cecum Ligation and Puncture-Induced Acute Lung Injury by Inhibiting Apoptosis of Alveolar Epithelial Cells"],"prefix":"10.1272","volume":"87","author":[{"given":"Jun","family":"Hagiwara","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Yamada","sequence":"additional","affiliation":[{"name":"Faculty of Medical Science, Nippon Sport Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Motoda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nippon Medical School Musashi Kosugi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315 (8):801-10.","DOI":"10.1001\/jama.2016.0287"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsuda A, Jacob A, Wu R, et al. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. J Nippon Med Sch. 2012;79 (1):4-18.","DOI":"10.1272\/jnms.79.4"},{"key":"3","unstructured":"3. Hagel S, Ludewig K, Frosinski J, et al. [Effectiveness of a hospital-wide educational programme for infection control to reduce the rate of health-care associated infections and related sepsis (ALERTS) --methods and interim results]. Dtsch Med Wochenschr. 2013;138 (34-35):1717-22. German."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Seymour CW, Rea TD, Kahn JM, Walkey AJ, Yealy DM, Angus DC. Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med. 2012;186 (12):1264-71.","DOI":"10.1164\/rccm.201204-0713OC"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Andrews P, Azoulay E, Antonelli M, et al. Year in review in intensive care medicine, 2004. I. Respiratory failure, infection, and sepsis. Intensive Care Med. 2005;31 (1):28-40.","DOI":"10.1007\/s00134-004-2529-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Beasley MB. The pathologist's approach to acute lung injury. Arch Pathol Lab Med. 2010;134 (5):719-27.","DOI":"10.5858\/134.5.719"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Esen F, Ozcan PE, Tuzun E, Boone MD. Mechanisms of action of intravenous immunoglobulin in septic encephalopathy. Rev Neurosci. 2018;29 (4):417-23.","DOI":"10.1515\/revneuro-2017-0065"},{"issue":"1","key":"8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40635-016-0114-1","volume":"5","author":"F Esen","year":"2017","unstructured":"8. Esen F, Orhun G, Ozcan PE, et al. Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis. Intensive care medicine experimental. 2017;5 (1):1.","journal-title":"Intensive Care Medicine Experimental","ISSN":"https:\/\/id.crossref.org\/issn\/2197-425X","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Abe Y. Therapeutic application of intravenous human natural immunoglobulin preparation. Front Biosci. 1996;1:e26-33.","DOI":"10.2741\/A140"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Noguchi T. High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med. 2008;34 (10):1812-9.","DOI":"10.1007\/s00134-008-1161-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yoshikawa T, Takeuchi H, Suda K, et al. High-dose immunoglobulin preparations improve survival in a CLP-induced rat model of sepsis. Langenbeck's archives of surgery. 2012;397 (3):457-65.","DOI":"10.1007\/s00423-011-0878-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Turgeon AF, Hutton B, Fergusson DA, et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med. 2007;146 (3):193-203.","DOI":"10.7326\/0003-4819-146-3-200702060-00009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nishida O, Ogura H, Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acute Med Surg. 2018;5 (1):3-89.","DOI":"10.1002\/ams2.322"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. McCuskey RS, Nishida J, McDonnell D, Baker GL, Urbaschek R, Urbaschek B. Effect of immunoglobulin G on the hepatic microvascular inflammatory response during sepsis. Shock (Augusta, Ga). 1996;5 (1):28-33.","DOI":"10.1097\/00024382-199601000-00007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nishida J, Ekataksin W, McDonnell D, Urbaschek R, Urbaschek B, McCuskey RS. Ethanol exacerbates hepatic microvascular dysfunction, endotoxemia, and lethality in septic mice. Shock (Augusta, Ga). 1994;1 (6):413-8.","DOI":"10.1097\/00024382-199406000-00004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res. 1980;29 (2):189-201.","DOI":"10.1016\/0022-4804(80)90037-2"},{"issue":"1","key":"17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40635-018-0197-y","volume":"6","author":"P Eyenga","year":"2018","unstructured":"17. Eyenga P, Roussel D, Morel J, et al. Time course of liver mitochondrial function and intrinsic changes in oxidative phosphorylation in a rat model of sepsis. Intensive care medicine experimental. 2018;6 (1):31.","journal-title":"Intensive Care Medicine Experimental","ISSN":"https:\/\/id.crossref.org\/issn\/2197-425X","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Seemann S, Zohles F, Lupp A. Comprehensive comparison of three different animal models for systemic inflammation. J Biomed Sci. 2017;24 (1):60.","DOI":"10.1186\/s12929-017-0370-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bhargava R, Altmann CJ, Andres-Hernando A, et al. Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-alpha antibodies. PLoS One. 2013;8 (11):e79037.","DOI":"10.1371\/journal.pone.0079037"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Murakami K, McGuire R, Cox RA, et al. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock (Augusta, Ga). 2002;18 (3):236-41.","DOI":"10.1097\/00024382-200209000-00006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Di Rosa R, Pietrosanti M, Luzi G, Salemi S, D'Amelio R. Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis? Eur J Intern Med. 2014;25 (6):511-6.","DOI":"10.1016\/j.ejim.2014.05.002"},{"key":"22","unstructured":"22. Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007;35 (12):2686-92."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Neilson AR, Burchardi H, Schneider H. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock. J Crit Care. 2005;20 (3):239-49.","DOI":"10.1016\/j.jcrc.2005.03.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev. 2013;CD001239.","DOI":"10.1002\/14651858.CD001239.pub4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pildal J, Gotzsche PC. Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis. 2004;39 (1):38-46.","DOI":"10.1086\/421089"},{"key":"26","unstructured":"26. Werdan K, Pilz G, Bujdoso O, et al. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med. 2007;35 (12):2693-701."},{"issue":"2","key":"27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/cc10597","volume":"16","author":"M Shankar-Hari","year":"2012","unstructured":"27. Shankar-Hari M, Spencer J, Sewell WA, Rowan KM, Singer M. Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Critical care (London, England). 2012;16 (2):206.","journal-title":"Critical Care","ISSN":"https:\/\/id.crossref.org\/issn\/1364-8535","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Negi VS, Elluru S, Siberil S, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007;27 (3):233-45.","DOI":"10.1007\/s10875-007-9088-9"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Bruhns P, Samuelsson A, Pollard JW, Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity. 2003;18 (4):573-81.","DOI":"10.1016\/S1074-7613(03)00080-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Fabrizio K, Groner A, Boes M, Pirofski LA. A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. Clin Vaccine Immunol. 2007;14 (4):382-90.","DOI":"10.1128\/CVI.00374-06"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hoffman JN, Fertmann JM, Vollmar B, Laschke MW, Jauch KW, Menger MD. Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock (Augusta, Ga). 2008;29 (1):133-9.","DOI":"10.1097\/shk.0b013e318123e5a6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Galeotti C, Hegde P, Das M, et al. Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin. Sci Rep. 2016;6:19592.","DOI":"10.1038\/srep19592"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Watanabe M, Uchida K, Nakagaki K, et al. High avidity cytokine autoantibodies in health and disease: pathogenesis and mechanisms. Cytokine Growth Factor Rev. 2010;21 (4):263-73.","DOI":"10.1016\/j.cytogfr.2010.03.003"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Murakami K, Suzuki C, Kobayashi F, et al. Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways. Naunyn Schmiedebergs Arch Pharmacol. 2012;385 (9):891-8.","DOI":"10.1007\/s00210-012-0765-8"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A. 2004;101 (1):296-301.","DOI":"10.1073\/pnas.2434651100"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ware LB, Matthay MA. The Acute Respiratory Distress Syndrome. New England Journal of Medicine. 2000;342 (18):1334-49.","DOI":"10.1056\/NEJM200005043421806"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147-63.","DOI":"10.1146\/annurev-pathol-011110-130158"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369 (9572):1553-64.","DOI":"10.1016\/S0140-6736(07)60604-7"},{"issue":"2","key":"39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc9994","volume":"15","author":"G Curley","year":"2011","unstructured":"39. Curley G, Hayes M, Laffey JG. Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI\/ARDS? Critical care (London, England). 2011;15 (2):212.","journal-title":"Critical Care","ISSN":"https:\/\/id.crossref.org\/issn\/1364-8535","issn-type":"print"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Riedemann NC, Neff TA, Guo RF, et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 2003;170 (1):503-7.","DOI":"10.4049\/jimmunol.170.1.503"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Simpson SQ, Casey LC. Role of tumor necrosis factor in sepsis and acute lung injury. Crit Care Clin. 1989;5 (1):27-47.","DOI":"10.1016\/S0749-0704(18)30449-4"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Galani V, Tatsaki E, Bai M, et al. The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract. 2010;206 (3):145-50.","DOI":"10.1016\/j.prp.2009.12.002"},{"key":"43","unstructured":"43. Ji Q, Sun Z, Yang Z, et al. Protective effect of ginsenoside Rg1 on LPS-induced apoptosis of lung epithelial cells. Mol Immunol. Forthcoming."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Faubel S. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis. 2008;15 (3):284-96.","DOI":"10.1053\/j.ackd.2008.04.008"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Singbartl K, Bishop JV, Wen X, et al. Differential effects of kidney-lung cross-talk during acute kidney injury and bacterial pneumonia. Kidney Int. 2011;80 (6):633-44.","DOI":"10.1038\/ki.2011.201"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Lin WC, Chen CW, Huang YW, et al. Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Sci Rep. 2015;5:12463.","DOI":"10.1038\/srep12463"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/87\/3\/87_JNMS.2020_87-303\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T11:23:45Z","timestamp":1665314625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/87\/3\/87_JNMS.2020_87-303\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2020_87-303","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]}}}